Picture of Qlife Holding AB logo

QLIFE Qlife Holding AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-75.46%
3m-75.73%
6m-87.33%
1yr-98.49%
Volume Change (%)
10d/3m+52.22%
Price vs... (%)
52w High-99.1%
50d MA-69.02%
200d MA-84.96%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equity-470.28%
Operating Margin-64197.13%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Qlife Holding AB EPS forecast chart

Profile Summary

Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    October 31st, 2019
    Public Since
    March 2nd, 2020
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    se flag iconOMX Nordic Exchange Stockholm
    Shares in Issue
    5,594,868,476
    Blurred out image of a map
    Address
    Redaregatan 48, HELSINGBORG, 252 36
    Web
    https://qlifeholding.com/
    Phone
    Auditors
    BDO Statsautoriseret Revisionsaktieselskab

    QLIFE Share Price Performance

    Upcoming Events for QLIFE

    Qlife Holding AB Annual Shareholders Meeting

    Similar to QLIFE

    Picture of Acarix AB logo

    Acarix AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of ADDvise AB (publ) logo

    ADDvise AB (publ)

    se flag iconOMX Nordic Exchange Stockholm

    Picture of ADDvise AB (publ) logo

    ADDvise AB (publ)

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Aegirbio AB logo

    Aegirbio AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Arcoma AB logo

    Arcoma AB

    se flag iconOMX Nordic Exchange Stockholm

    FAQ

    0